Dividend Declaration

Summary by AI ^BETAClose X

International Biotechnology Trust PLC has declared its first interim dividend for the year ending 31 August 2026, amounting to 15.64 pence per ordinary share. This dividend represents an annualised yield of 3.2% based on the closing share price of 974 pence on 11 December 2025. The ex-dividend date is 29 December 2025, with the record date on 30 December 2025 and payment scheduled for 23 January 2026. This distribution aligns with the company's policy of paying dividends equivalent to 4% of its net asset value as at the previous financial year-end.

Disclaimer*

Intl. Biotechnology Trust PLC

15 December 2025

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

First interim dividend for the year ending 31 August 2026

At the Annual General Meeting of International Biotechnology Trust plc (the "Company") held on 12 December 2025, shareholders approved the Company's dividend policy of making dividend payments, equivalent to 4% of the Company's net asset value as at the last day of the preceding financial year (31 August 2025), through two equal semi-annual distributions.

The Directors have declared the payment of a first interim dividend of 15.64 pence per ordinary share for the year ending 31 August 2026.

As at 11 December 2025, the latest practicable date prior to publication of this announcement, the interim dividend of 15.64 pence per share represents an annualised yield of 3.2% calculated with reference to the Company's closing share price of 974 pence that day.

Ex-dividend date:	29 December 2025
Record date:	30 December 2025
Payment date:	23 January 2026
Dividend per share:	15.64 pence

Enquiries:

Natalia de Sousa

Schroder Investment Management Limited

Tel: 020 7658 6000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END